Oct 9, 2023 · An evidence-based consensus meeting was held with urologists, a pharmacist and a cardiologist to perform a structured benefit-risk analysis of reclassifying tadalafil, a …

Dec 13, 2022 · The aim of this study was to evaluate the clinical outcomes of patients in acute phase of Peyronie’s disease (PD) treated with daily low-dose of Tadalafil.

Jan 4, 2006 · The aim of this article is to critically review the available evidence from the tadalafil clinical research program and give the physician a rational approach for intervention in the …

Feb 1, 2018 · In this systematic review and meta-analysis, we aim to review the efficacy of once daily to on-demand tadalafil for the treatment of ED, thereby adding evidence to the role of …

Feb 13, 2023 · Erectile dysfunction questionnaires were administered to 20 patients with type 2 diabetes (T2DM) and ED. The safety and efficacy of tadalafil were evaluated using laboratory …

We examined randomized controlled trials and observational studies that examined the use of tadalafil for at least 8 weeks of follow-up with the primary outcome of International Index for …

Jul 1, 2025 · Appropriate studies performed to date have not demonstrated geriatric-specific problems that would limit the usefulness of tadalafil in the elderly. However, elderly patients …

Dec 13, 2018 · This review discusses tadalafil and its analogues reported in the past 15 years. It discusses synthetic pathways, structural activity relationships, existing and future …

Nov 1, 2004 · To assess the efficacy and safety of daily tadalafil, a potent selective phosphodiesterase 5 inhibitor, for the treatment of erectile dysfunction (ED) in men previously …

Mar 15, 2017 · We aimed to evaluate the efficacy of tadalafil 5 mg once-daily treatment on testosterone levels in patients with erectile dysfunction (ED) accompanied by the metabolic …